[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 117
Citations 0
Lab Reports
January 4, 2012

Target for Thyroid Cancer

JAMA. 2012;307(1):24. doi:10.1001/jama.2011.1907

Thyroid tumors carrying mutations in the BRAF gene depend on the mutant protein produced by the gene, and inhibiting the gene leads to tumor regression in mice, a new study shows (Chakravarty D et al. J Clin Invest. doi:10.1172/JCI46382 [published online November 21, 2011]).

BRAF gene mutations are found in about one-quarter of papillary carcinomas, the most common form of thyroid cancer, and are even more common in high-grade carcinomas, particularly those that resist radioiodine treatment.

First Page Preview View Large
First page PDF preview
First page PDF preview
×